What is the recommended evaluation and management for fibrous dysplasia of the temporal bone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fibrous Dysplasia of Temporal Bone

For fibrous dysplasia of the temporal bone, the majority of patients should be managed conservatively with clinical observation alone, reserving surgery only for specific complications including external auditory canal stenosis with cholesteatoma, progressive conductive hearing loss, or intractable otorrhea.

Initial Evaluation

Clinical Assessment

Look specifically for:

  • Hearing loss (present in 29-100% of symptomatic cases) 1, 2
  • Cosmetic deformity (50% of cases) 1
  • Headache (59% of cases) 1
  • Otorrhea (36.4% of cases) 2
  • External auditory canal stenosis - the most common temporal bone manifestation 3, 4

Imaging Protocol

CT temporal bone without IV contrast is your primary imaging modality 5. This provides:

  • Excellent anatomic detail of bony structures
  • Assessment of external auditory canal stenosis
  • Detection of cholesteatoma (occurs in 3% of temporal bone FD) 1
  • Evaluation of otic capsule involvement (usually preserved) 4

The classic radiographic appearance shows ground-glass opacity with cortical thinning 6.

Disease Patterns to Recognize

Monostotic vs. Polyostotic:

  • Only 11% have monostotic disease limited to temporal bone 1
  • 89% have polyostotic involvement 1
  • 24% have McCune-Albright syndrome 1

Critical finding: No patients in the largest temporal bone series (n=66) had motor cranial neuropathy 1, making this a reassuring natural history.

Management Algorithm

Conservative Management (Majority of Patients)

Most patients experience a benign course and can be followed clinically without intervention 1. This is appropriate when:

  • Asymptomatic or minimal symptoms
  • No external auditory canal stenosis
  • No cholesteatoma
  • Stable hearing
  • No cerebrospinal fluid leak

Surgical Indications

Operate only for:

  1. External auditory canal stenosis with cholesteatoma (most common surgical indication)

    • Perform canaloplasty combined with wide meatoplasty 2
    • Canaloplasty shows the best hearing outcomes: 84% improvement, 18% stable hearing 7
    • Cholesteatoma develops secondary to EAC occlusion, particularly at the osteochondral junction 2
  2. Progressive conductive hearing loss from canal stenosis 4

  3. Persistent otorrhea unresponsive to medical management 4

  4. Spontaneous CSF fistula (rare: 1.5% of cases) 1

Surgical Approach Details

When surgery is indicated:

  • Canaloplasty with wide meatoplasty is the procedure of choice 2
  • Tympanomastoidectomy if middle ear cholesteatoma present 4
  • Avoid aggressive resection in growing children - lesions progress until puberty 8
  • Median follow-up shows excellent prognosis with appropriate surgical selection 2

Critical Pitfalls to Avoid

  1. Over-treatment: The growing number of incidentally discovered cases on imaging should NOT prompt intervention unless symptomatic 1

  2. Age considerations: Surgery in patients <16 years has higher recurrence risk 9. Balance intervention need against growth potential.

  3. Cholesteatoma surveillance: External auditory canal stenosis creates a closed space predisposing to cholesteatoma - this is the main complication requiring intervention 4, 2

  4. Otic capsule: Involvement is unusual 4, but when present may cause sensorineural hearing loss (seen in 2 patients in one series) 2

Follow-up Strategy

For conservatively managed patients:

  • Serial clinical examinations monitoring for canal stenosis
  • Audiometry to detect progressive hearing loss
  • Otoscopy to identify early cholesteatoma
  • Repeat CT only if clinical deterioration occurs

The mean follow-up duration in the literature is 48 months, demonstrating the chronicity and generally benign nature of this condition 1.

References

Research

Fibrous Dysplasia of Temporal Bone.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022

Research

Fibrous dysplasia: rare manifestation in the temporal bone.

Brazilian journal of otorhinolaryngology, 2022

Guideline

acr appropriateness criteria® inflammatory ear disease.

Journal of the American College of Radiology, 2025

Research

Fibrous dysplasia: Rare sphenoidal and parietal involvement.

Surgical neurology international, 2025

Research

Fibrous dysplasia of the temporal bone: systematic review of management and hearing outcomes.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2014

Research

Childhood fibrous dysplasia.

Orthopaedics & traumatology, surgery & research : OTSR, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.